Open figure viewer
In April 2025, in Haridwar, India, Acharya Balkrishna, the Managing Director and chief executive officer of Patanjali Ayurved Ltd., faced a complex brand management dilemma. The company had recently received regulatory approval for its US$540m acquisition of Magma General Insurance, marking its formal entry into India’s highly regulated general insurance sector. Known for its roots in Ayurveda, Swadeshi positioning and rapid diversification across fast-moving consumer goods (FMCG) and wellness categories, Patanjali had built its identity around health, purity and tradition. However, recent reputational setbacks, including product recalls and regulatory scrutiny, had begun to erode consumer trust, which is a critical...
You do not currently have access to this content.
